Sec. 800.4. Access to medication assisted treatment

(a) All programs certified pursuant to this Part shall expeditiously facilitate access to medication assisted treatment, based on the clinical need and preference of the patient, through direct provision of the medication, contracting with private prescribing professionals or linkage agreements with other office certified programs. Such agreements must ensure access sufficient to meet patient needs without undue barriers such as long waiting periods for appointments or waiting lists.

(b) All doctors, physician assistants and nurse practitioners employed in a treatment program certified pursuant to this Part must have a Federal DATA 2000 waiver regarding treatment with buprenorphine.

(c) Any doctors, physician assistants and nurse practitioners required to have a Federal DATA 2000 waiver must do so by March 1, 2019 or within six months of date of hire, whichever is latest.

(d) All programs must allow for provision of medication assisted treatment and may not deny admission based on use of medication. Programs must continue access to opioid full and partial agonist treatment and plan for the continuity of medication administration.

(e) All programs must maintain an emergency medical kit at each certified or funded location; such kit must include basic first aid and at least one naloxone emergency overdose prevention kit such that it is available for use during all program hours of operation.

(f) Each program that dispenses medications must develop and implement a diversion control plan (DCP) as part of its quality improvement plan, such DCP to include specific measures to reduce the possibility for diversion of controlled substances from legitimate treatment use and shall assign specific responsibility to the medical and administrative staff of the program for carrying out the diversion control measures and functions described in the DCP.